Philip Morris International Inc. (PM)
Can Philip Morris Rely on Pricing to Drive 2025 EPS Growth?
Philip Morris International PM continues to lean on pricing as a key earnings driver. The company delivered a strong first quarter of 2025, with adjusted earnings per share (EPS) rising 12.7% year over year to $1.69.
Stocks rally on hopes Israel-Iran conflict will subside, Phillip Morris stock hits records
Asking for a Trend anchor Josh Lipton breaks down the latest market trends for June 16, 2025. US stocks close higher on hopes the Israel-Iran conflict remains contained.
Bull of the Day: Philip Morris Intl (PM)
Philip Moriss is strategically evolving beyond its traditional cigarette business, exemplified by the remarkable success of its "Zyn" oral nicotine patch.
ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?
PM sees smoke-free products drive 44% of Q1 profit as ZYN and IQOS momentum redefines its future beyond tobacco.
Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?
PM stock soars 50.1% year to date, fueled by smoke-free growth, premium pricing and bullish earnings momentum.
Philip Morris International, Inc. (PM) dbAccess Global Consumer Conference Call Transcript
Philip Morris International, Inc. (NYSE:PM ) dbAccess Global Consumer Conference Call June 3, 2025 5:15 AM ET Company Participants Emmanuel Babeau - CFO Conference Call Participants Damian McNeela - Deutsche Bank Damian McNeela Good morning, everybody. I think we will make a start.
This Isn't The Philip Morris You Think It Is
Philip Morris is leading the industry transition to smoke-free products, with 42% of revenue now from alternatives like IQOS and Zyn. Strong Q1 2025 results—10.2% organic revenue growth, rising margins, and raised earnings guidance—demonstrate robust financial health and execution. Despite a premium valuation and some regulatory and competitive risks, PM's stable cash flow and dividend growth justify a strong buy rating.
Phillip Morris's Undeniable Market Leadership Comes At Too Great A Cost
PM's market leadership in the tobacco market across combustible and smoke-free approaches has been well rewarded indeed, as observed in the premium valuations and inflated stock prices. These have been well supported by the growing net revenues, the expanding shipment volumes, and the richer adj operating margins, significantly aided by the US FDA approval for ZYN. This is on top of the rich cash flow story, with PM's dividend remaining safe despite the management's intensified US-based capex thus far.
Philip Morris (PM) Up 3% Since Last Earnings Report: Can It Continue?
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock?
PM Stock Up 6.9% Post Q1 Earnings: A Green Light for Investors?
PM shows strong growth prospects, driven by its successful shift to smoke-free products, solid first-quarter results and optimistic guidance.
Philip Morris: A Bold Pivot That Worked
Philip Morris has successfully pivoted from cigarettes to non-combustible products, with IQOS leading the charge, achieving significant market share and revenue milestones. IQOS, PM's heat-not-burn brand, has outpaced traditional cigarette sales, particularly in Japan, and contributed $11B to PM's $15B smoke-free revenues in 2024. PM's acquisition of Swedish Match and its Zyn brand has bolstered its position in the oral nicotine market, adding $2B in sales and high margins in the critical US market.
Top Wall Street analysts are bullish on these 3 dividend stocks for stable returns
TipRanks' analyst ranking service spotlights three dividend-paying stocks, including AT&T and Texas Instruments.
